Sanofi/Takeda, UniQure & CSL, Fog Pharma, Merck + Imago
Failed to add items
Add to basket failed.
Add to Wish List failed.
Remove from Wish List failed.
Follow podcast failed
Unfollow podcast failed
Sanofi/Takeda, UniQure & CSL, Fog Pharma, Merck + Imago
-
Narrated by:
-
By:
About this listen
Vaccine hesitancy, the most expensive gene therapy in the world, a $178M series D, and a $1.3B buyout
Find out more at
https://LifeScienceTodayPodcast.com
Story References
Sanofi/Takeda
UniQure & CSL
Fog Pharma
Merck + Imago
About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.